{"filing":{"accession_number":"0001437749-26-024597","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"amix20260728_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926024597/amix20260728_8k.htm"},"events":[{"id":20985,"run_id":18906,"accession_number":"0001437749-26-024597","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.55,"summary":"The disclosure reports a cash balance of $5.1 million and 971,043 shares outstanding as of July 28, 2026, following a warrant inducement on July 13, 2026. While the cash position and share count are material facts for investors assessing the company's financial condition and capitalization, the disclosure does not fit neatly into standard event categories—it is neither a specific financial event (debt issuance, impairment, etc.) nor a governance or operational action. The reference to the warrant inducement suggests dilutive activity, but the filing does not detail the inducement terms or consequences. This appears to be a financial snapshot disclosure that is material but does not align with a named event type.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20505,"accession_number":"0001437749-26-024597","item_number":"8.01","item_title":"Other Events","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.55,"reasoning":"The disclosure reports a cash balance of $5.1 million and 971,043 shares outstanding as of July 28, 2026, following a warrant inducement on July 13, 2026. While the cash position and share count are material facts for investors assessing the company's financial condition and capitalization, the disclosure does not fit neatly into standard event categories—it is neither a specific financial event (debt issuance, impairment, etc.) nor a governance or operational action. The reference to the warrant inducement suggests dilutive activity, but the filing does not detail the inducement terms or consequences. This appears to be a financial snapshot disclosure that is material but does not align with a named event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T15:37:40.314092+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20505,"accession_number":"0001437749-26-024597","item_number":"8.01","item_title":"Other Events","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.55,"reasoning":"The disclosure reports a cash balance of $5.1 million and 971,043 shares outstanding as of July 28, 2026, following a warrant inducement on July 13, 2026. While the cash position and share count are material facts for investors assessing the company's financial condition and capitalization, the disclosure does not fit neatly into standard event categories—it is neither a specific financial event (debt issuance, impairment, etc.) nor a governance or operational action. The reference to the warrant inducement suggests dilutive activity, but the filing does not detail the inducement terms or consequences. This appears to be a financial snapshot disclosure that is material but does not align with a named event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T15:37:40.314092+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-28"}]}